Skip to content

GRX GABELLI HEALTHCARE & WELLNES

Follow

SHS (fund), issuer CIK 1391437

Filings received so far for Q3 2026: 1 13F filer report a position in GRX shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

The latest Form 4 transactions, non-derivative.
OwnerDateSharesPriceFiling
Saba Capital Management, L.P.10% owner2026-10-08+400 P$9.4Form 4
Saba Capital Management, L.P.10% owner2026-10-07+2,955 P$9.43Form 4
Saba Capital Management, L.P.10% owner2026-10-06+4,439 P$9.41Form 4
Saba Capital Management, L.P.10% owner2026-10-05+1,775 P$9.38Form 4

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
WEALTH ENHANCEMENT ADVISORY SERVICES, L…22,566$217K<0.01%+38013F-HRTimeline

Events

  • Saba Capital Management, L.P. bought 400 GRX shares on 2026-10-08, Form 4 filed 2026-10-13. 0001510281-26-000340

    Accepted , ingested
  • Saba Capital Management, L.P. bought 2,955 GRX shares on 2026-10-07, Form 4 filed 2026-10-09. 0001510281-26-000335

    Accepted , ingested
  • Saba Capital Management, L.P. bought 4,439 GRX shares on 2026-10-06, Form 4 filed 2026-10-08. 0001510281-26-000331

    Accepted , ingested
  • Saba Capital Management, L.P. bought 1,775 GRX shares on 2026-10-05, Form 4 filed 2026-10-07. 0001510281-26-000327

    Accepted , ingested